Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RMED will - over the next 2 Weeks and hit - by . In that time frame, RMED's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
RMED shares rose +10.00% in Thursday, August 17, 2023's trading session, rising from a previous close of $0.54 to move at $0.59. The stock demonstrated notable intraday movement (see RMED's key stats for a full breakdown), fluctuating between $0.52 and $0.59, a +14.23% trading range. While recent weeks have seen some volatility, RMED has managed to secure a +9.80% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 40.92K shares changing hands, 33.5K more than the previous session. This amounted to $24.30K in total market activity.
Will RMED Continue Its Trend?
According to analyst ratings and projections for RMED, Ra Medical Systems, Inc. shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for RMED currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 17 negative trading days within the past 30 sessions. Based on the RMED stock forecast, now is not the best time to buy RMED stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on RMED covering social and institutional perspectives.
RMED Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RMED's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 45.18% to 54.32%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 39.55%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 40.83%, maintains a neutral outlook for the long term. Insights into RMED's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Ra Medical Systems, Inc. Monthly Forecast 2024
September 2024
According to our latest forecast models, Ra Medical Systems, Inc. (RMED) is positioned to show a strong performance in September 2024. The price is predicted to move between $0.00 and $5.46, settling at an average of $0.00. This could translate to a -100.00% loss.
RMED's history of dividends and stock splits also plays a role in long-term investor confidence.